Utah Medical Products, Inc. (UTMD)
USD 56.43
(-1.54%)
USD 56.43
(-1.54%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 30.03 Million USD | -24.38% |
| 2022 | 32.19 Million USD | 4.14% |
| 2021 | 30.91 Million USD | 21.02% |
| 2020 | 25.54 Million USD | -13.3% |
| 2019 | 29.46 Million USD | 12.01% |
| 2018 | 26.3 Million USD | -0.34% |
| 2017 | 26.39 Million USD | 11.42% |
| 2016 | 23.69 Million USD | -2.05% |
| 2015 | 24.18 Million USD | -3.19% |
| 2014 | 24.98 Million USD | 2.93% |
| 2013 | 24.27 Million USD | -4.09% |
| 2012 | 25.3 Million USD | 12.98% |
| 2011 | 22.4 Million USD | 69.57% |
| 2010 | 13.21 Million USD | -4.2% |
| 2009 | 13.78 Million USD | -8.18% |
| 2008 | 15.01 Million USD | -4.88% |
| 2007 | 15.78 Million USD | -2.22% |
| 2006 | 16.14 Million USD | 2.5% |
| 2005 | 15.75 Million USD | 4.56% |
| 2004 | 15.06 Million USD | -5.2% |
| 2003 | 15.89 Million USD | 0.82% |
| 2002 | 15.76 Million USD | 2.4% |
| 2001 | 15.39 Million USD | 1.77% |
| 2000 | 15.12 Million USD | -15.92% |
| 1999 | 17.98 Million USD | 10.36% |
| 1998 | 16.3 Million USD | 15.6% |
| 1997 | 14.1 Million USD | -31.55% |
| 1996 | 20.6 Million USD | -2.83% |
| 1995 | 21.2 Million USD | 12.17% |
| 1994 | 18.9 Million USD | 8.0% |
| 1993 | 17.5 Million USD | 4.17% |
| 1992 | 16.8 Million USD | 30.23% |
| 1991 | 12.9 Million USD | 30.3% |
| 1990 | 9.9 Million USD | 33.78% |
| 1989 | 7.4 Million USD | 45.1% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 5.27 Million USD | 1.01% |
| 2024 Q2 | 5.74 Million USD | -15.1% |
| 2024 Q1 | 6.76 Million USD | 8.6% |
| 2023 Q2 | 7.73 Million USD | 0.0% |
| 2023 FY | 24.34 Million USD | -24.38% |
| 2023 Q3 | 7.35 Million USD | -4.91% |
| 2023 Q4 | 6.23 Million USD | -15.34% |
| 2023 Q1 | - USD | -100.0% |
| 2022 FY | 32.19 Million USD | 4.14% |
| 2022 Q1 | 7.53 Million USD | -7.14% |
| 2022 Q4 | 8.32 Million USD | 1.73% |
| 2022 Q2 | 8.15 Million USD | 8.2% |
| 2022 Q3 | 8.18 Million USD | 0.43% |
| 2021 Q1 | 6.94 Million USD | -4.38% |
| 2021 FY | 30.91 Million USD | 21.02% |
| 2021 Q4 | 8.11 Million USD | 0.48% |
| 2021 Q3 | 8.07 Million USD | 3.7% |
| 2021 Q2 | 7.78 Million USD | 12.06% |
| 2020 FY | 25.54 Million USD | -13.3% |
| 2020 Q1 | 6.83 Million USD | -12.52% |
| 2020 Q3 | 6.49 Million USD | 31.25% |
| 2020 Q4 | 7.26 Million USD | 11.82% |
| 2020 Q2 | 4.95 Million USD | -27.59% |
| 2019 Q4 | 7.81 Million USD | 5.9% |
| 2019 Q1 | 6.77 Million USD | 10.92% |
| 2019 FY | 29.46 Million USD | 12.01% |
| 2019 Q2 | 7.5 Million USD | 10.73% |
| 2019 Q3 | 7.37 Million USD | -1.61% |
| 2018 FY | 26.3 Million USD | -0.34% |
| 2018 Q1 | 6.92 Million USD | 6.99% |
| 2018 Q3 | 6.29 Million USD | -9.88% |
| 2018 Q4 | 6.1 Million USD | -2.99% |
| 2018 Q2 | 6.98 Million USD | 0.9% |
| 2017 Q4 | 6.47 Million USD | -0.4% |
| 2017 Q2 | 6.89 Million USD | 5.48% |
| 2017 FY | 26.39 Million USD | 11.42% |
| 2017 Q1 | 6.53 Million USD | 20.13% |
| 2017 Q3 | 6.49 Million USD | -5.76% |
| 2016 FY | 23.69 Million USD | -2.05% |
| 2016 Q1 | 6.22 Million USD | 5.56% |
| 2016 Q2 | 6.25 Million USD | 0.47% |
| 2016 Q3 | 5.77 Million USD | -7.63% |
| 2016 Q4 | 5.44 Million USD | -5.8% |
| 2015 Q3 | 6.07 Million USD | -0.33% |
| 2015 FY | 24.18 Million USD | -3.19% |
| 2015 Q2 | 6.09 Million USD | -0.21% |
| 2015 Q1 | 6.11 Million USD | -4.32% |
| 2015 Q4 | 5.89 Million USD | -3.03% |
| 2014 Q2 | 6.34 Million USD | 4.94% |
| 2014 Q4 | 6.38 Million USD | 3.1% |
| 2014 FY | 24.98 Million USD | 2.93% |
| 2014 Q3 | 6.19 Million USD | -2.41% |
| 2014 Q1 | 6.05 Million USD | 0.93% |
| 2013 Q1 | 6.28 Million USD | 4.32% |
| 2013 FY | 24.27 Million USD | -4.09% |
| 2013 Q2 | 6.04 Million USD | -3.71% |
| 2013 Q3 | 5.94 Million USD | -1.64% |
| 2013 Q4 | 5.99 Million USD | 0.76% |
| 2012 Q1 | 6.73 Million USD | 13.99% |
| 2012 FY | 25.3 Million USD | 12.98% |
| 2012 Q3 | 6.47 Million USD | 6.69% |
| 2012 Q2 | 6.07 Million USD | -9.91% |
| 2012 Q4 | 6.02 Million USD | -7.04% |
| 2011 Q1 | 3.71 Million USD | 12.94% |
| 2011 Q4 | 5.91 Million USD | -9.3% |
| 2011 Q2 | 6.26 Million USD | 68.73% |
| 2011 Q3 | 6.51 Million USD | 4.12% |
| 2011 FY | 22.4 Million USD | 69.57% |
| 2010 FY | 13.21 Million USD | -4.2% |
| 2010 Q4 | 3.28 Million USD | -1.53% |
| 2010 Q3 | 3.33 Million USD | 2.11% |
| 2010 Q2 | 3.26 Million USD | -1.69% |
| 2010 Q1 | 3.32 Million USD | -3.79% |
| 2009 Q4 | 3.45 Million USD | -1.31% |
| 2009 FY | 13.78 Million USD | -8.18% |
| 2009 Q3 | 3.5 Million USD | 4.95% |
| 2009 Q2 | 3.33 Million USD | -4.71% |
| 2009 Q1 | 3.5 Million USD | 2.61% |
| 2008 Q1 | 3.75 Million USD | -3.15% |
| 2008 Q3 | 3.93 Million USD | 0.41% |
| 2008 Q4 | 3.41 Million USD | -13.36% |
| 2008 FY | 15.01 Million USD | -4.88% |
| 2008 Q2 | 3.92 Million USD | 4.53% |
| 2007 FY | 15.78 Million USD | -2.22% |
| 2007 Q4 | 3.87 Million USD | -2.52% |
| 2007 Q3 | 3.97 Million USD | -0.82% |
| 2007 Q2 | 4 Million USD | 1.75% |
| 2007 Q1 | 3.93 Million USD | -3.79% |
| 2006 FY | 16.14 Million USD | 2.5% |
| 2006 Q1 | 4 Million USD | 0.6% |
| 2006 Q2 | 4.07 Million USD | 1.75% |
| 2006 Q4 | 4.09 Million USD | 3.05% |
| 2006 Q3 | 3.97 Million USD | -2.6% |
| 2005 FY | 15.75 Million USD | 4.56% |
| 2005 Q4 | 3.98 Million USD | -0.77% |
| 2005 Q3 | 4.01 Million USD | -0.2% |
| 2005 Q2 | 4.02 Million USD | 7.71% |
| 2005 Q1 | 3.73 Million USD | 6.59% |
| 2004 Q2 | 3.93 Million USD | 2.18% |
| 2004 Q3 | 3.77 Million USD | -3.94% |
| 2004 Q4 | 3.5 Million USD | -7.3% |
| 2004 FY | 15.06 Million USD | -5.2% |
| 2004 Q1 | 3.85 Million USD | -1.33% |
| 2003 Q2 | 4.03 Million USD | 1.41% |
| 2003 Q4 | 3.9 Million USD | -1.94% |
| 2003 FY | 15.89 Million USD | 0.82% |
| 2003 Q1 | 3.97 Million USD | 0.66% |
| 2003 Q3 | 3.97 Million USD | -1.34% |
| 2002 FY | 15.76 Million USD | 2.4% |
| 2002 Q1 | 3.81 Million USD | 0.1% |
| 2002 Q2 | 3.91 Million USD | 2.65% |
| 2002 Q3 | 4.07 Million USD | 4.14% |
| 2002 Q4 | 3.95 Million USD | -3.14% |
| 2001 Q2 | 3.92 Million USD | 4.2% |
| 2001 Q3 | 3.89 Million USD | -0.64% |
| 2001 Q4 | 3.81 Million USD | -2.16% |
| 2001 FY | 15.39 Million USD | 1.77% |
| 2001 Q1 | 3.76 Million USD | 0.29% |
| 2000 Q2 | 3.87 Million USD | 5.5% |
| 2000 Q3 | 3.82 Million USD | -1.14% |
| 2000 Q4 | 3.75 Million USD | -2.01% |
| 2000 Q1 | 3.67 Million USD | -21.69% |
| 2000 FY | 15.12 Million USD | -15.92% |
| 1999 Q2 | 4.3 Million USD | 2.38% |
| 1999 Q3 | 4.7 Million USD | 9.3% |
| 1999 Q4 | 4.68 Million USD | -0.26% |
| 1999 Q1 | 4.2 Million USD | -6.67% |
| 1999 FY | 17.98 Million USD | 10.36% |
| 1998 Q4 | 4.5 Million USD | 4.65% |
| 1998 FY | 16.3 Million USD | 15.6% |
| 1998 Q1 | 3.7 Million USD | -5.13% |
| 1998 Q2 | 3.9 Million USD | 5.41% |
| 1998 Q3 | 4.3 Million USD | 10.26% |
| 1997 Q2 | 3 Million USD | 0.0% |
| 1997 Q4 | 3.9 Million USD | -7.14% |
| 1997 Q3 | 4.2 Million USD | 40.0% |
| 1997 FY | 14.1 Million USD | -31.55% |
| 1997 Q1 | 3 Million USD | -40.0% |
| 1996 FY | 20.6 Million USD | -2.83% |
| 1996 Q4 | 5 Million USD | -5.66% |
| 1996 Q3 | 5.3 Million USD | -1.85% |
| 1996 Q2 | 5.4 Million USD | 10.2% |
| 1996 Q1 | 4.9 Million USD | -12.5% |
| 1995 Q1 | 4.8 Million USD | -2.04% |
| 1995 Q2 | 5.4 Million USD | 12.5% |
| 1995 FY | 21.2 Million USD | 12.17% |
| 1995 Q4 | 5.6 Million USD | 3.7% |
| 1995 Q3 | 5.4 Million USD | 0.0% |
| 1994 Q1 | 4.5 Million USD | 9.76% |
| 1994 FY | 18.9 Million USD | 8.0% |
| 1994 Q4 | 4.9 Million USD | 4.26% |
| 1994 Q3 | 4.7 Million USD | -2.08% |
| 1994 Q2 | 4.8 Million USD | 6.67% |
| 1993 Q3 | 4.4 Million USD | -8.33% |
| 1993 Q4 | 4.1 Million USD | -6.82% |
| 1993 Q1 | 4.2 Million USD | -10.64% |
| 1993 FY | 17.5 Million USD | 4.17% |
| 1993 Q2 | 4.8 Million USD | 14.29% |
| 1992 FY | 16.8 Million USD | 30.23% |
| 1992 Q3 | 4.5 Million USD | 12.5% |
| 1992 Q1 | 3.6 Million USD | -5.26% |
| 1992 Q4 | 4.7 Million USD | 4.44% |
| 1992 Q2 | 4 Million USD | 11.11% |
| 1991 Q2 | 3 Million USD | 11.11% |
| 1991 FY | 12.9 Million USD | 30.3% |
| 1991 Q4 | 3.8 Million USD | 15.15% |
| 1991 Q3 | 3.3 Million USD | 10.0% |
| 1991 Q1 | 2.7 Million USD | -10.0% |
| 1990 Q3 | 2.7 Million USD | 17.39% |
| 1990 Q2 | 2.3 Million USD | 15.0% |
| 1990 Q1 | 2 Million USD | -23.08% |
| 1990 Q4 | 3 Million USD | 11.11% |
| 1990 FY | 9.9 Million USD | 33.78% |
| 1989 Q4 | 2.6 Million USD | 30.0% |
| 1989 Q2 | 1.4 Million USD | -63.16% |
| 1989 Q1 | 3.8 Million USD | -15.56% |
| 1989 Q3 | 2 Million USD | 42.86% |
| 1989 FY | 7.4 Million USD | 45.1% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AtriCure, Inc. | 300.37 Million USD | 90.0% |
| Avinger, Inc. | 2 Million USD | -1399.651% |
| Azenta, Inc. | 263.14 Million USD | 88.585% |
| BioLife Solutions, Inc. | 46.75 Million USD | 35.75% |
| Daxor Corporation | 1.1 Million USD | -2622.214% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -230.851% |
| GlucoTrack, Inc. | -13 Thousand USD | 231161.538% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 50.649% |
| Hologic, Inc. | 2.22 Billion USD | 98.652% |
| ICU Medical, Inc. | 739.87 Million USD | 95.94% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 99.365% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -79.779% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 25272.422% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 25272.422% |
| Masimo Corporation | 1 Billion USD | 97.007% |
| NEXGEL, Inc. | 619 Thousand USD | -4752.666% |
| NEXGEL, Inc. | 619 Thousand USD | -4752.666% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 5483.154% |
| Pro-Dex, Inc. | 14.55 Million USD | -106.433% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 2588.65% |
| Predictive Oncology Inc. | 1.14 Million USD | -2522.726% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -418.095% |
| QuidelOrtho Corporation | 1.49 Billion USD | 97.99% |
| Sanara MedTech Inc. | 57.13 Million USD | 47.428% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 3470.33% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 98.56% |
| Jin Medical International Ltd. | 6.78 Million USD | -342.723% |